Skip to Content Skip to Content

Medicine

Reset All Filters
1794 Results
From clinic to classroom: How two physicians are rethinking healthcare through business
Samuel Nathan, a doctor from Ghana, and Dan Menéndez, a U.K.-trained physician

Samuel Nathan (left) and Dan Menéndez, students in the Wharton MBA and Lauder Institute MA in International Studies joint-degree program

(Image: Courtesy of The Lauder Institute)

From clinic to classroom: How two physicians are rethinking healthcare through business

The Wharton MBA and Lauder Institute MA in International Studies joint-degree program emphasizes regional expertise, culture, and policy so its students can learn to develop health care solutions.

From the Lauder Institute

2 min. read

A different way of thinking about side effects
A person holding a prescription pill bottle in their hand.

Image: Catherine McQueen via Getty Images

A different way of thinking about side effects

The new book “Side Effects: The Social Ecology of Adverse Drug Reactions,” by sociologist Jason Schnittker and former Ph.D. student Duy Do, makes the case that side effects are a product of social, cultural, and institutional forces.

3 min. read

Immune protein a possible target to slow Parkinson’s disease
Neuron cell network

Image: koto_feja via Getty Images

Immune protein a possible target to slow Parkinson’s disease

Researchers at Penn Medicine have found that blocking a key neuronal protein interrupts the spread of toxins to healthy neurons in preclinical studies.

Eric Horvath

1 min. read

Most who meet proposed CTE criteria do not show disease signs at autopsy
 Gloved hand holding a scan of four brains

Image: pangoasis via Getty Images

Most who meet proposed CTE criteria do not show disease signs at autopsy

New research from Penn Medicine finds proposed traumatic encephalopathy syndrome criteria often don’t match CTE pathology at autopsy, raising concerns about misdiagnosis and potential mental health impacts for at-risk groups.

Kelsey Geesler

2 min. read

Specialized RNA molecules could counter ALS neurodegeneration
Microscopic view of mRNA

Image: Courtesy of Penn Medicine

Specialized RNA molecules could counter ALS neurodegeneration

Researchers at Penn Medicine have discovered short RNA chaperones that bind to the primary target of ALS, restore its function, and protect motor neurons in a preclinical model, pointing toward a new RNA-based therapeutic strategy.

From Penn Medicine News

2 min. read

Bringing hope to uterine health patients

Bringing hope to uterine health patients

Physician-scientist Kate O’Neill directs innovative research that helps people suffering from infertility, endometriosis, and other issues build families and have excellent quality-of-life.

1 min. read

Empowering unhoused patients through comprehensive eye care
From left to right: Justin Wang, Janine Haros, and Eric Lee in a clinical room at the Scheie Eye Institute, holding documents and smiling together

Justin Wang (left), Janine Haros (center), and Eric Lee (right) in a clinical room at the Scheie Eye Institute, holding documents and smiling together.

nocred

Empowering unhoused patients through comprehensive eye care

Penn fourth-years Eric Lee, Janine Haros, and Justin Wang will use a President’s Engagement Prize to elevate vision health in unhoused individuals across Philadelphia through free eye screenings, tailored care coordination, and interactive patient education.

4 min. read

Using AI to help predict cardiac arrests
A doctor looking at EKG heart data.

Image: SimpleImages via Getty Images

Using AI to help predict cardiac arrests

A Penn Engineering and Penn Medicine team built CAMEL, an artificial intelligence model that forecasts dangerous cardiac rhythms before they strike. Their findings pave the way for a new era of real-time, predictive heart care.

2 min. read